About Daikso

Daikso’s Journey

2021
Technical Breakthroughs
- Ranked No.1 – “Paper with Code” AI Ranking
- 8th place(1200+ teams) -in validation phase BraTS 2021, MICCAI
- Ranked No.1 – Adaptive Computing Challenge 2021, AMD-Xilinx
- The only 1 polyp detection AI library serving in AMD-Xilinx AI Library
- Ranked No.2 – MedAI 2021 in instrument segmentation
- Ranked No.3 – MedAI 2021 in polyp segmentation
2022
Foundation & Seed Growth
- Ranked No.1 in MICCAI DFUC 2022
- Completed development of a lightweight AI framework
- Angel round fundraising: NTD 12.7M
- Officially registered in Taiwan
2023 ~ 2024
Regulatory & Taiwan collaboration
- Completed the prototype of a real-time mobile AI inference system
- Approved in 2023 by the Ministry of Digital Affairs: AI Program II (Total Funding: NTD 12M)
- Pre-A round fundraising: NTD 20M
- QMS Approval (QMS5518)
- Got 4 TFDA (MOHW-MD-(I) 010221、010267、010275、010293)
2025 ~
Commercialization & Oversea market entry
- Established Hong Kong subsidiary
- QMS approval (QMS2351)
- MDSAP certification – ISO 13485 approval
- 2025 Computex InnoVEXContests: Top 10 startup companies

2021